Aditxt Chairman and General Counsel Resign Amid Delisting Threat and Going Concern Warning
ADTX is trading near its 52-week low of $0.056 (6.4% above the low) on elevated volume (6.8× avg).
Summary
Aditxt, Inc. announced the immediate resignations of its non-executive Chairman of the Board and its General Counsel, Chief People Officer, and Corporate Secretary, adding to concerns for the company already facing delisting and a 'going concern' warning.
Key Events · Executive and Board Changes · ADTX
-
Chairman of the Board Resigns
Brian Brady resigned as non-executive Chairman of the Board and as a member of the Board, effective June 2, 2026. Mr. Brady also served as Chair of the Audit Committee and was a member of the Compensation and Nominating and Corporate Governance Committees.
-
General Counsel and CPO Resigns
Christopher J. Porcelli resigned as General Counsel, Chief People Officer, and Corporate Secretary, effective June 2, 2026.
Analysis · ADTX · Life Sciences
The resignations of the non-executive Chairman of the Board (who also chaired the Audit Committee) and the General Counsel/Chief People Officer are critical. These departures signal a significant loss of leadership and governance expertise at a time when Aditxt is facing severe financial distress, a Nasdaq delisting notice, and a 'going concern' warning. Such high-level exits can further erode investor confidence and complicate efforts to address the company's existential challenges.
At the time of this filing, ADTX was trading at $0.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $50.7K. The 52-week trading range was $0.06 to $53,450.61. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.